Philippe Sansonetti
21Patents
5h-index
34Co-inventors
69Inventor score
Filing activity: Jul 12, 1985 → Aug 22, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4816389A | "Probe for DNA and a process for the detection of ""shigellae"" and entero-invasive strains of Escherichia coli" | Emerging Cross-Sectional Technologies | 31 | Expired |
| US6528061B1 | Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6136542A | Method for screening for inhibitors and activators of type III secretion machinery in gram-negative bacteria | Chemistry; Metallurgy | 7 | Expired |
| US4992364A | "Probe for DNA and a process for the detection of ""Shigellae"" and entero-invasive strains of Escherichia coli" | Emerging Cross-Sectional Technologies | 6 | Expired |
| US8124380B2 | Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri | Emerging Cross-Sectional Technologies | 6 | Active |
| US5762941A | Modified shigella having reduced pathogenicity | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7892772B2 | Targeted ubiquitination of proteins and screening methods using a new class of ubiquitin ligase proteins | Chemistry; Metallurgy | 2 | Active |
| US10138280B2 | Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their nucleic acids and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US7138126B2 | Transformed Shigella | Emerging Cross-Sectional Technologies | 1 | Expired |
| US9382299B2 | Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their nucleic acids and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US7078165B2 | Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof | Emerging Cross-Sectional Technologies | 0 | Expired |
| US11725183B2 | Method of culturing segmented filamentous bacteria in vitro | Emerging Cross-Sectional Technologies | 0 | Active |
| US10087242B2 | Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X | Chemistry; Metallurgy | 0 | Active |
| US7396812B2 | Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof | Emerging Cross-Sectional Technologies | 0 | Expired |
| US8092989B2 | Targeting the histone code as a bacterial strategy for selectively modulating gene expression | Emerging Cross-Sectional Technologies | 0 | Active |
| US8815239B2 | Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X | Chemistry; Metallurgy | 0 | Active |
| US10376593B2 | Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri | Emerging Cross-Sectional Technologies | 0 | Active |
| US7439053B2 | Transformed Shigella | Emerging Cross-Sectional Technologies | 0 | Active |
| US9446109B2 | Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri | Emerging Cross-Sectional Technologies | 0 | Active |
| US9663833B2 | Single cell based reporter assay to monitor gene expression patterns with high spatio-temporal resolution | Chemistry; Metallurgy | 0 | Active |
| US6696249B1 | Method for screening for inhibitors and activators of type III secretion machinery in gram-negative bacteria | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.